Resources

There are a number of studies saying that calcium supplements may not be heart safe.

In this exclusive interview, Dr. Claude Lardinois discusses genetic risk factors for cardiovascular issues in diabetes patients, the impact of smoking on amputations, and why albumin is a driver of cardiovascular disease.

In part 2 of this exclusive interview from AACE 2016, Dr. Claude Lardinois discusses why albumin is a driver of cardiovascular disease.

Which party do you believe will be a champion for diabetes research, prevention, and treatment? 1) Democrats 2) Republicans 3) Independents 4) None of the above 5) Not sure Follow the link to share your opinion and see what your colleagues think.

The new class of drugs, SGLT-2 Inhibitors, have been shown to have positive results; which one is false? 1. Reduces BP 2. Reduces Uric Acid 3. Reduces Glucagon 4. Reduces Glucose 5. Reduces Oxidative Stress 6. Reduces Hypotension 7. Reduces HF Risk Did you get the right answer? Follow the link to find out!

It’s never too early to start talking about the holidays with our patients. For some, it’s a holiday almost every night. Man, 76 years of age, visits with his wife for obesity and type 2 diabetes management. Despite diabetes education, including medical nutritional therapy and medication, he was not losing weight nor were his glucose levels improving…especially his bedtime glucose levels.

Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 5, the final installment of this Exclusive Interview, Dr. Handelsman stresses the need for physicians to take the time to learn the recommendations for best treating diabetes.

In this week's Homerun Slides, the approach that shows how earlier and more aggressive type 2 diabetes intervention may improve a patient's chance to reach management goals.

Glucagon, discovered in 1923 as a contaminant of early insulin preparations, has long been a neglected hormone. Glucagon was among the very first polypeptide hormones to be isolated, purified, sequenced, and synthesized. Thanks to the pioneering work of Unger, it was the first polypeptide hormone to become measurable by radioimmunoassay, almost one year before insulin. It has served two Nobel Prize winners as a unique tool, which permitted Sutherland and his associates to discover cyclic AMP (cAMP), and Rodbell and his coworkers to discover the role of G-proteins in cell-membrane receptors.

New approach reduces significant errors from about one in three to about one in 10.